Ribociclib improves progression-free survival in Asian women with advanced breast cancer
LUGANO-SINGAPORE, 17 December, 2016 - Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial...








